32 results
8-K
ir8zc5s0jnxc6 1a
5 Dec 22
Regulation FD Disclosure
7:39am
8-K
EX-99.1
zkzmaq
5 Dec 22
Regulation FD Disclosure
7:39am
8-K
EX-99.2
1qhkne272qi5lpbi0 6r
5 Dec 22
Regulation FD Disclosure
7:39am
8-K
EX-99.2
jr50s 6pp1lb4mn
25 Apr 22
Nkarta Announces Positive Preliminary Dose Finding Data for Two Lead Engineered Natural Killer Cell Programs
7:52am
8-K
EX-99.1
276x1ydh
17 Mar 22
Nkarta Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights
4:11pm
8-K
p7jhu5oe
7 Oct 21
Nkarta Announces Updates to NKX019 and NKX101 Clinical Development Programs
4:09pm
8-K
EX-99.1
r3urk8suomxij8xj1
7 Oct 21
Nkarta Announces Updates to NKX019 and NKX101 Clinical Development Programs
4:09pm